- Home
- BCRX vs PEB Comparison
BCRX vs PEB Comparison
Compare BCRX & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | PEB |
|---|---|---|
| Founded | 1986 | 2009 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BCRX | PEB |
|---|---|---|
| Price | $7.24 | $12.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $20.82 | $12.35 |
| AVG Volume (30 Days) | ★ 4.2M | 2.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.21 | $2.04 |
| Revenue Next Year | $6.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.00 | $7.42 |
| 52 Week High | $11.31 | $13.11 |
Technical Indicators
Market Signals| Indicator | BCRX | PEB |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 63.60 |
| Support Level | $6.26 | $12.22 |
| Resistance Level | $6.91 | $12.97 |
| Average True Range (ATR) | 0.27 | 0.45 |
| MACD | 0.10 | 0.08 |
| Stochastic Oscillator | 97.13 | 86.49 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.